论文部分内容阅读
Background:Current therapies for chronic hepatitis B(CHB) afford durable post-treatment responses in a minority of patients.
Preclinical and Early Clinical Profile of NVR 3-778,a Potential First-In-Class HBV Core Inhibitor
【摘 要】
：
Background:Current therapies for chronic hepatitis B(CHB) afford durable post-treatment responses in a minority of patients.
【作 者】
：
【机 构】
：
Auckland Clinical Studies Novira Therapeutics
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
其他文献
Hepatitis B surface antigen(HBsAg) seroclearance rarely occurs in patients with chronic hepatitis B(CHB).The annual incidence of spontaneous HBsAg seroclerance is estimated to be approximately 0.1-0.8
会议
1.Ontogenetic differences have genetic background?There may be individual genetic background whether hepatitis B aggravate.
会议
Enhanced Cholesterol synthesis in HepG2 Cells by HCV Core Protein Through SREBP2-mediated Signal Tra
Hepatic steatosis is a common feature in patients with chronic hepatitis C virus(HCV) infection.HCV core protein plays an important role in the development of hepatic steatosis in HCV infection.
会议
Chronic infection with hepatitis B virus(HBV) contributes to more than three quarters of hepatocellular carcinoma(HCC) cases worldwide.It remains a great challenge to know how HBV causes HCC.
会议
Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations o
Background:Chronic hepatitis B virus(HBV) infection and subsequent chronic inflammation are major risk factors of hepatocellular carcinoma(HCC) in China.
会议
Interferon-alfa(IFN-α) has dual mode of actions of inhibiting hepatitis B virus(HBV) DNA replication and modulating the host immune response against HBV.1 Pegylated formation of interferon-alfa(pegint
会议
Epidemiology and lamivudine resistance of hepatitis B virus infection in human immunodeficiency viru
Aims:To investigate the prevalence of HBV in HIV-infected adults in Guangdong province and assess the frequency of lamivudine(3TC) resistance mutations in HIV/HBV co-infected patients treated with 3TC
会议
A New Method Dedicated for Evaluating Hepatic Cirrhosis Based on the Strategy of Structural Quantifi
Background:Chronic hepatitis B virus(HBV) infection and subsequent chronic inflammation are major risk factors of hepatocellular carcinoma(HCC) in China.
会议
Impaired anti-fibrotic activity of NK cells is dependent on hepatic stellate cells-derived TGF-β and
Background:Natural killer(NK) cells have been implicated in inducing fibrosis remission in mice model;however,their roles in fibrotic progression remain to be elucidated in patients with liver fibrosi
会议
Continuous Elevation of Circulating Th22 cells and IL-22 Levels in HBV Related Acute-on-Chronic Live
Background:T-helper(Th) 22 cells and IL-22 are linked to the development of inflammatory and autoimmune disease.Acute-on-chronic liver failure(ACLF) is an increasingly recognised entity encompassing a
会议